Overview

Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
In this study we, the investigators at the Centre for Addiction and Mental Health, intend to explore whether bupropion is able to reduce smokers' responses to cigarette-related environmental cues, and craving. Previous studies have indicated that bupropion may be able to achieve these outcomes. Therefore, we predict that smokers treated with bupropion for several weeks will show reduced reactivity to cigarette cues and craving.
Phase:
Phase 1
Details
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborator:
Canadian Institutes of Health Research (CIHR)
Treatments:
Bupropion
Nicotine